|
Name |
L-2-Aminoadipic acid
|
Molecular Formula | C6H11NO4 | |
IUPAC Name* |
(2S)-2-aminohexanedioic acid
|
|
SMILES |
C(C[C@@H](C(=O)O)N)CC(=O)O
|
|
InChI |
InChI=1S/C6H11NO4/c7-4(6(10)11)2-1-3-5(8)9/h4H,1-3,7H2,(H,8,9)(H,10,11)/t4-/m0/s1
|
|
InChIKey |
OYIFNHCXNCRBQI-BYPYZUCNSA-N
|
|
Synonyms |
L-2-Aminoadipic acid; 1118-90-7; (S)-2-aminohexanedioic acid; (2S)-2-aminohexanedioic acid; L-alpha-Aminoadipic acid; L-alpha-Aminoadipate; L-2-Aminoadipate; (S)-2-Aminoadipic acid; L-2-Aminohexanedioate; hexanedioic acid, 2-amino-, (2S)-; l-2-amino adipic acid; homoglutamic acid; 2-Aminoadipic acid, L-; h-l-2-aad-oh; Hexanedioic acid, 2-amino-, (S)-; Aminoadipate; CHEMBL88804; 88ZH74L7SR; CHEBI:37023; L-aminoadipic acid; L-Homoglutamic acid; MFCD00002636; DL-alpha-Aminoadipate; Adipic acid, 2-amino-; l-a-aminoadipic acid; L-.alpha.-Aminoadipic acid; alpha-Aminoadipate, L-; L-alpha-Aminoadipatic acid; UNII-88ZH74L7SR; a-Aminoadipate; a-Aminoadipic acid; DL-a-Aminoadipate; UN1; DL-2-Aminoadipate; h-2-aad-oh; DL-a-Aminoadipic acid; l-a-aminohexanoic acid; (S)-Aminoadipic Acid; DL-2-Aminohexanedioate; alpha-Amino-adipic acid; L-2-amino-adipic acid; ALHA-AMINOADIPATE; (S)-2-Aminoadipicacid; aminoadipic acid, l-2-; L -alpha-aminoadipic acid; (+/-)-2-Aminoadipate; L-2-Aminohexanedioic acid; (2S)-2-aminoadipic acid; L- alpha -Aminoadipic acid; l-alpha-aminohexanedioic acid; Lopac0_000091; SCHEMBL97323; (S)-2-amino-hexanedioic acid; L-.ALPHA.-AMINOADIPATE; (2S)-2-Amino-hexanedioic Acid; DTXSID801017096; HMS3260C04; ZINC1532798; Tox21_500091; BDBM50052553; AKOS015920301; CCG-204186; CS-W014381; LP00091; SDCCGSBI-0050079.P002; HEXANEDIOIC ACID, 2-AMINO-, L-; L-2-Aminoadipic acid, >=98% (TLC); NCGC00093593-01; NCGC00093593-02; NCGC00093593-03; NCGC00093593-04; NCGC00260776-01; AS-13597; EU-0100091; EN300-97272; A 7275; C00956; 118A907; SR-01000075684; J-002657; SR-01000075684-1; Q27104392; Aad; (S)-2-Aminohexanedioic acid; L-Homoglutamic acid; 9EF7020B-8995-4D0E-BE44-34D8F18766DF
|
|
CAS | 1118-90-7 | |
PubChem CID | 92136 | |
ChEMBL ID | CHEMBL88804 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 161.16 | ALogp: | -3.1 |
HBD: | 3 | HBA: | 5 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 101.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 11 | QED Weighted: | 0.53 |
Caco-2 Permeability: | -6.025 | MDCK Permeability: | 0.00566659 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.05 |
Human Intestinal Absorption (HIA): | 0.09 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0.002 |
Blood-Brain-Barrier Penetration (BBB): | 0.483 | Plasma Protein Binding (PPB): | 12.35% |
Volume Distribution (VD): | 0.326 | Fu: | 78.91% |
CYP1A2-inhibitor: | 0.005 | CYP1A2-substrate: | 0.023 |
CYP2C19-inhibitor: | 0.036 | CYP2C19-substrate: | 0.042 |
CYP2C9-inhibitor: | 0.017 | CYP2C9-substrate: | 0.479 |
CYP2D6-inhibitor: | 0.039 | CYP2D6-substrate: | 0.146 |
CYP3A4-inhibitor: | 0.015 | CYP3A4-substrate: | 0.005 |
Clearance (CL): | 8.53 | Half-life (T1/2): | 0.695 |
hERG Blockers: | 0.011 | Human Hepatotoxicity (H-HT): | 0.053 |
Drug-inuced Liver Injury (DILI): | 0.013 | AMES Toxicity: | 0.025 |
Rat Oral Acute Toxicity: | 0.021 | Maximum Recommended Daily Dose: | 0.009 |
Skin Sensitization: | 0.134 | Carcinogencity: | 0.059 |
Eye Corrosion: | 0.006 | Eye Irritation: | 0.111 |
Respiratory Toxicity: | 0.081 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000550 | 0.545 | D00ENY | 0.767 | ||||
ENC000137 | 0.545 | D01JIA | 0.559 | ||||
ENC000123 | 0.500 | D0X5SI | 0.514 | ||||
ENC000937 | 0.500 | D0F5DO | 0.475 | ||||
ENC000142 | 0.475 | D06VNK | 0.455 | ||||
ENC000062 | 0.455 | D0Z0MG | 0.452 | ||||
ENC000760 | 0.417 | D0EP8X | 0.438 | ||||
ENC000075 | 0.400 | D0Y7ZD | 0.417 | ||||
ENC000315 | 0.361 | D01OPV | 0.417 | ||||
ENC005079 | 0.358 | D02UDJ | 0.406 |